U.S. In Vitro Diagnostics Quality Control Market Size & Outlook

The in vitro diagnostics quality control market in the United States is expected to reach a projected revenue of US$ 625.1 million by 2030. A compound annual growth rate of 3.1% is expected of the United States in vitro diagnostics quality control market from 2024 to 2030.
Revenue, 2023 (US$M)
$503.1
Forecast, 2030 (US$M)
$625.1
CAGR, 2024 - 2030
3.2%
Report Coverage
U.S.

U.S. in vitro diagnostics quality control market, 2018-2030 (US$M)

U.S.

Related Markets

U.S. in vitro diagnostics quality control market highlights

  • The U.S. in vitro diagnostics quality control market generated a revenue of USD 503.1 million in 2023 and is expected to reach USD 625.1 million by 2030.
  • The U.S. market is expected to grow at a CAGR of 3.1% from 2024 to 2030.
  • In terms of segment, controls was the largest revenue generating product in 2023.
  • Calibrators is the most lucrative product segment registering the fastest growth during the forecast period.


In vitro diagnostics quality control market data book summary

Market revenue in 2023USD 503.1 million
Market revenue in 2030USD 625.1 million
Growth rate3.1% (CAGR from 2023 to 2030)
Largest segmentControls
Fastest growing segmentCalibrators
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationControls, Calibrators
Key market players worldwideSiemens Healthineers AG ADR, Abbott Laboratories, Bio-Rad Laboratories Inc, Danaher Corp, Roche Holding AG ADR, Sysmex Corp, QuidelOrtho Corp, Thermo Fisher Scientific Inc, BD, Merck KGaA, Qiagen NV, Hologic Inc, Bio-Techne Corp, Randox, Helena Laboratories, Seracare Life Sciences, Fortress Diagnostics, Microbiologics, TRINA BIOREACTIVES, Cone Bioproducts, Biorex Food Diagnostics


Other key industry trends

  • In terms of revenue, U.S. accounted for 39.3% of the global in vitro diagnostics quality control market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. in vitro diagnostics quality control market is projected to lead the regional market in terms of revenue in 2030.
  • U.S. is the fastest growing regional market in North America and is projected to reach USD 625.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

In Vitro Diagnostics Quality Control Market Scope

In Vitro Diagnostics Quality Control Market Companies

Name Profile # Employees HQ Website

U.S. in vitro diagnostics quality control market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro diagnostics quality control market will help companies and investors design strategic landscapes.


Controls was the largest segment with a revenue share of 48.34% in 2023. Horizon Databook has segmented the U.S. in vitro diagnostics quality control market based on controls, calibrators covering the revenue growth of each sub-segment from 2018 to 2030.


The high prevalence of targeted diseases such as cancer, infectious diseases, and cardiovascular diseases, among others, is increasing the demand for testing solutions, which is further driving the IVD quality control market. 

According to the American Cancer Society’s estimates, in 2022, around 1.9 million new cases of cancer are estimated to be diagnosed in the U.S., which is expected to lead to around 609,360 deaths. In addition, during the COVID‐19 outbreak, several U.S.-based companies were involved in extensive R&D of novel diagnostic tests. 

Thus, there is a high demand for quality control in diagnostics. The presence of leading market players, such as Siemens Healthineers AG; Bio-Rad Laboratories, Inc.; Thermo Fisher Scientific Inc; and QuidelOrtho Corporation; is also a key driver of the market in the country. 

Reasons to subscribe to U.S. in vitro diagnostics quality control market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of U.S. in vitro diagnostics quality control market databook

  • Our clientele includes a mix of in vitro diagnostics quality control market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the U.S. in vitro diagnostics quality control market , including forecasts for subscribers. This country databook contains high-level insights into U.S. in vitro diagnostics quality control market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

U.S. in vitro diagnostics quality control market size, by product, 2018-2030 (US$M)

U.S. In Vitro Diagnostics Quality Control Market Outlook Share, 2023 & 2030 (US$M)

U.S. in vitro diagnostics quality control market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more